Sunday, September 20, 2026

Peloton Stock Plummets 31% In 21 Sessions, Investors Wary

ViaNews Editorial Team

September 7, 2023

Peloton Stock Plummets 31% In 21 Sessions, Investors Wary

(VIANEWS) - Peloton shares have declined by 31.22% over 21 sessions on NASDAQ, closing at EUR5.86 on December 15th. Peloton (NASDAQ: PTON) shares have experienced a dramatic decrease over the last 21 sessions, falling 31.22% from EUR8.52 on August 8th to EUR5.86 at 15:25 EST Thursday afternoon. This significant drop came following three straight sessions of losses on NASDAQ (-0.93% to EUR13,743.40). Peloton's last closing price of EUR6.10 marks a 65.79% drop from its 52-week high of EUR17.83, reflecting investors' worries regarding recent performance issues that caused it to experience such a substantial share price drop. Peloton has recently experienced increased competition in the fitness industry, which may have contributed to its share price decline. Furthermore, market volatility and concerns regarding economic prospects may have had an effect on investors' decisions as well. Peloton's recent performance has been cause for alarm, and investors will closely follow its future developments to assess its long-term prospects.

About Peloton

Peloton Interactive, Inc. is a pioneering provider of connected fitness products, offering an interactive platform that streams both live and on-demand classes through touchscreen devices. Their product lineup consists of the Peloton Bike, Peloton Bike+, Tread & Tread+ models as well as guides & rows which they market and sell directly through retail showrooms or onepeloton.com; since 2012 they've operated globally.

Yearly Analysis

Here is a clear investment outlook for Peloton stock: Peloton's stock is currently trading at EUR5.86, which is significantly below its 52-week high of EUR17.83 but still higher than its 52-week low of EUR5.05, suggesting some fluctuations over the past year. Peloton anticipates negative 0.6% sales growth this year; however, 6.6% sales growth for 2019 suggests the company may make an improvement next year. Peloton's EBITDA stands at an encouraging 1.3, which bodes well for its financial health. However, EBITDA should not be seen as a replacement measure for net income and should only be seen as an indicator. Overall, Peloton stock may be considered high-risk investment due to its extreme volatility and negative sales growth this year; however, its anticipated sales growth and positive EBITDA may make it attractive for investors willing to assume higher levels of risk. Before making any decisions based on speculation alone, investors should conduct further research by reviewing financial statements, industry trends, and economic conditions before making their final investment decisions.

Technical Analysis

Peloton's stock price has been on an ongoing downward trend, falling below both its 50-day and 200-day moving averages and suggesting momentum loss for both short and long term investments. Today's trading volume of 6,169,738 represents significantly less trading interest in Peloton compared with its average volume of 11,025,200 which could indicate potential investors have no desire to take up shares of Peloton. Peloton's current intraday variation average has been positive 1.64% over the past week, negative 1.44% over the last month and positive 4.19% over the last quarter. The highest amplitude of average volatility over this timeframe has been 1.64% (week), 3.93% (month), and 4.19% (quarter). Stochastic oscillator estimates show that Peloton's stock price has become oversold (=20), suggesting a potential buying opportunity for investors. It should be remembered, however, that stock prices may be affected by various external factors; investors should conduct thorough research and analysis prior to making any definitive investment decisions.

Quarter Analysis

According to available data, Peloton's current sales growth for the quarter is negative 4.3%; however, company estimates for current and subsequent quarters show growth estimates of 69.2% and 57.1% respectively. Peloton's year-over-year quarterly revenue growth has dropped 5.4% compared to last year, reaching an all-time high of 2.8 billion for twelve-month trailing revenue. Although sales growth may have decreased, Peloton still experiences positive revenue growth at a slower pace compared to before. Peloton's growth projections for the upcoming quarter appear relatively optimistic compared to its negative performance during this quarter, so investors should watch how Peloton performs over the course of these upcoming quarters to assess if these estimates can be attained. Overall, its outlook appears mixed - both positive and negative indicators may exist within its growth outlook.

Equity Analysis

Peloton's trailing twelve month earnings per share (EPS) are negative at EUR-3.37, demonstrating that it did not generate profits over the past year per share. Additionally, Peloton's Return on Equity (ROE) for the last twelve trailing months stands at an alarming negative figure -847.35% indicating it has failed to produce profits efficiently and effectively while using shareholder's equity to generate returns for itself. Overall, Peloton's financial metrics demonstrate its current challenges regarding profitability and ROE. Investors should carefully consider these elements alongside any relevant financial data before making investment decisions.

More news about Peloton (PTON).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com